Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Biogen Inc. Faces Setbacks in Pipeline and Leqembi Sales

December 09, 2024
Fmr LLC, a renowned investment firm, has recently divested 229,202 shares of Biogen Inc. (NASDAQ:BIIB), thereby reducing its stake in the company. This move comes as Biogen Inc. faces challenges in its pipeline and experiences a slowdown in sales of its drug, Leqembi.

The pharmaceutical giant, Biogen Inc., has been downgraded by financial analysts due to setbacks in its pipeline and a decline in Leqembi sales. This downgrade has caused concerns among investors and analysts alike.

In a recent development, XTX Topco Ltd, a leading trading firm, has purchased 6,955 shares of Biogen Inc., indicating their confidence in the company's future performance. This move also reflects the potential growth prospects that Biogen Inc. holds in the market.

Several leading brokerages have set a target price of $257.20 for Biogen Inc. (NASDAQ:BIIB), suggesting a positive outlook for the company's stock. Investors are advised to consult professionals from Stocks Prognosis for expert guidance on predicting the future movement of Biogen Inc.'s shares.

Despite facing setbacks in its pipeline and a slowdown in Leqembi sales, Biogen Inc. remains a prominent player in the pharmaceutical industry. Investors are recommended to stay informed about the latest developments in the company and seek expert advice to make informed decisions regarding their investment in Biogen Inc.

Find out how the BIOGEN INC. rate is expected to change

Get Forecast for BIIB

Investor opinions & comments:

It's encouraging to see leading brokerages setting a positive target price for Biogen Inc., suggesting potential growth for the company
— from RyanKing at 12-12-2024 20:44
I'm skeptical about Biogen Inc.'s ability to bounce back from these setbacks and deliver positive results
— from JeremiahSnyder at 12-12-2024 18:54
Investors should consider staying informed about Biogen Inc.'s latest developments and seek advice from experts to make well-informed investment decisions
— from EllaFlores at 12-11-2024 23:52
I wonder how Biogen Inc. plans to address their challenges in the pipeline and revitalize Leqembi sales
— from BrittanyClark at 12-11-2024 17:06
I'm uncertain about the future prospects of Biogen Inc. given the recent downgrades and challenges they are facing
— from JessicaMoore at 12-11-2024 09:30
Biogen Inc. is still a prominent player in the pharmaceutical industry despite the setbacks, which is a positive sign for investors
— from DividendDylan at 12-11-2024 01:48
I have doubts about the effectiveness of Leqembi and its potential to generate significant sales for Biogen Inc
— from LucasPrice at 12-11-2024 01:36
I'm interested to see how XTX Topco Ltd's purchase of Biogen Inc. shares will impact the company's future performance
— from TraderTara at 12-10-2024 20:11
I'm curious to see how Biogen Inc. will overcome these setbacks and regain momentum in their pipeline and Leqembi sales
— from EllaFlores at 12-10-2024 15:13
If you want to leave a comment, then you need Login or Register





Other news for BIIB

BIIBJune 11, 2025Biogen Inc. Presents Exciting Advances at Goldman Sachs Conference  ~1 min.

Biogen Inc. recently presented at the Goldman Sachs 46th Annual Global Healthcare Conference, showcasing their latest innovations in the healthcare sector....

BIIBApril 7, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 13.05% Profit  ~1 min.

In a recent development on QuantWave, the stock of Biogen Inc. has successfully reached the price target forecast, resulting in a profitable outcome for users....

BIIBApril 6, 2025Biogen Inc. Continues to Struggle with Declining Earnings and Investor Returns  ~2 min.

Biogen Inc., a leading biotechnology company, has reported a significant decrease in company earnings, losing a staggering US$697 million....

BIIBApril 4, 2025Biogen Inc. Stock Hits QuantWave Forecast Target with 11.12% Profit  ~2 min.

Biogen Inc. stock recently achieved the price target forecast set by QuantWave, signaling a successful prediction for investors....

BIIBApril 4, 2025Biogen Inc. Hits Price Target Forecast on QuantWave with 12.72% Profit  ~1 min.

Biogen Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.72%. The forecast signal was issued on March 21, 2025, when the stock was priced at 140.9 $....



Related news

BIIBFebruary 26, 2025Biogen Inc. BIIB: Innovative Pharmaceutical Stock with Promising Growth Potential  ~2 min.

Biogen Inc. (NASDAQ:BIIB) is being recognized as one of the cheap pharmaceutical stocks to buy, according to analysts at Yahoo Finance....

BIIBDecember 15, 2024Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. NASDAQ:BIIB  ~1 min.

Recently, Inspire Trust Co. N.A. has increased its stock holdings in Biogen Inc. (NASDAQ:BIIB), expressing its confidence in the company's future prospects. Biogen Inc....

BIIBFebruary 22, 2025We Think Biogens NASDAQ:BIIB Healthy Earnings Might Be Conservative  ~2 min.

Biogen Inc. (NASDAQ:BIIB) has recently reported strong earnings, but some believe that these numbers may be conservative....

BIIBDecember 14, 2024"Biogen Inc. Faces Challenges as Financials Show Mixed Results"  ~1 min.

Biogen Inc. (NASDAQ:BIIB) is experiencing struggles with its stock price as a result of its mixed financials. Inspire Trust Co. N.A. has recently increased its stock holdings in the company....

BIIBJanuary 2, 2025Biogen Inc. Positioned as a Top Value Stock for the Long-Term  ~2 min.

Biogen Inc. (NASDAQ:BIIB) is emerging as a top value stock for long-term investors....